New data platform transforms prediction and understanding of Alzheimer’s disease
A powerful new real-world data platform could transform how scientists predict and understand Alzheimer’s disease and Alzheimer’s disease related dementias…
A powerful new real-world data platform could transform how scientists predict and understand Alzheimer’s disease and Alzheimer’s disease related dementias…
Panic buying doesn’t just respond to shortages – it creates them. And according to a University of the Sunshine Coast behavioral scientist, the lessons…
Life’s Essential 8 (LE8) and Life’s Crucial 9 (LC9) from the American Heart Association are industry-accepted metrics that summarize overall…
Women who frequently sought healthcare for recurring symptoms before the pandemic were more likely to later be diagnosed with post-COVID,…
Burnout is at an all-time high, with some studies saying two-thirds of employees now cite job burnout as a major…
Researchers from King’s College London and the University of Surrey have developed a new technique to measure the content of…
Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted therapies, tucatinib and trastuzumab, plus the chemotherapy drug, capecitabine, may improve symptoms and extend survival…
Aptamer Group plc, the developer of next‑generation synthetic binders for the life sciences industry, today announced the launch of a…
ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh’s Roslin…
One of the symptoms of schizophrenia is difficulty incorporating new information about the world. This can lead patients to struggle…